exp date isn't null, but text field is
This guidance replaces the previous guidelines "Acute asthma in children aged between 2 and 5 years" and "Acute asthma in children > 5 years"
Separate guidance is available for Acute asthma in children aged < 2 years.
MILD AND
|
MODERATE AND
|
SEVERE AND
|
LIFE THREATENING AND
|
If YES to any of the above then patient should be discussed with on call Paediatric Registrar prior to discharge.
Salbutamol MDI + Spacer – Initial therapy = 10 puffs. (100mcg per puff)
Oxygen – minimum 6 l/min via non-rebreather mask
Prednisolone |
2 -4yrs 20mg OD >5yrs 40mg OD |
Nebulised medication for Severe Wheeze | |
2 -4yrs |
Salbutamol 2.5mg |
>5yrs |
Salbutamol 5mg |
IV MEDICATION
(To be prescribed as per the Escalation to IV therapy care pathway)
1. Magnesium sulphate injection |
40mg/kg over 20 minutes (max 2gram) |
||||
2. Aminophylline |
|
||||
3. Salbutamol |
|
||||
- Hydrocortisone - Ondansetron |
4mg/kg QDS (max 100mg) 100micrograms/kg (max 4mg) |
Patients with MILD asthma at 1st assessment can be discharged after Salbutamol without being monitored for 4 hours |
Last reviewed: 11 June 2020
Next review: 30 June 2022
Author(s): Dr Steve Foster (Consultant in Paediatric Emergency – Paediatric Emergency Department), Dr Morag Wilson (Consultant in General Paediatrics – Acute Paediatrics)
Approved By: Clinical Effectiveness